TrialPath
★ Asthma

Asthma clinical trials — recruiting now

There are 20+ asthma studies currently recruiting participants across the US. Every eligibility criterion translated into plain English.

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

NCT05222529 · Asthma
Recruiting

The purpose of this study is to characterize the bronchodilator effect, systemic exposure and safety/tolerability of two different doses of inhaled glycopyrronium, when compared to placebo. Outcome of this study will be used to determine the dose of inhaled glycopyrronium for the development of fixed dose combination indacaterol/mometasone/glycopyrronium (QVM149) for children aged 6 to less than 12 years old with moderate to severe asthma.

PhasePhase 2
TypeInterventional
Age6 Years – 11 Years
WhereRousse, Bulgaria + 22 more
SponsorNovartis Pharmaceuticals
▾Tap for details
Apply

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

NCT07120503 · Asthma
Recruiting

This is a global Phase 2 study divided in two parts. Part A is a double-blind, randomized dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivotal trials for efficacy and safety. Part B is a pivotal double-blind, randomized study to demonstrate the efficacy and safety of WIN378 in adults with severe uncontrolled asthma. Two dose levels of WIN378 will be tested against placebo to evaluate AAER, lung function, asthma control, asthma-related quality of life and other important efficacy endpoints.

PhasePhase 2
TypeInterventional
Age18 Years – 75 Years
WhereLos Angeles, California, United States + 72 more
SponsorWindward Bio
▾Tap for details
Apply

Remote Monitoring of Asthma in Children and Young People

NCT07129616 · Asthma Childhood, Asthma Attack, Remote Monitoring
Recruiting

The objective of this study is to determine whether healthcare data and remotely collected patient data can accurately predict asthma attacks in children and young people aged 5-17 years. The main outcome is: when using this new system, is there a reduction in asthma attacks compared with a historic average. The whole population of children and young people with asthma will have routine healthcare data monitored, with a subset of people with high risk asthma asked to participate in a more detail study involving remotely monitored data.

Phase—
TypeObservational
Age5 Years – 17 Years
WhereEdinburgh, United Kingdom
SponsorUniversity of Edinburgh
▾Tap for details
Apply

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

NCT06691971 · Subject Presenting Wheeze, Asthma, Bronchial Disease
Recruiting

Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.

Phase—
TypeObservational
Age3 Years
WhereThe Bronx, New York, United States
SponsorAevice Health Pte. Ltd.
▾Tap for details
Apply

Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)

Recruiting

The mainstay of asthma treatment are ICSs, mostly combined with LABA. In the past decade LAMA had been accepted as an add-on treatment for patients at GINA steps 4 and 5. Recently, RCTs proved the efficacy and safety of fixed triple combinations of moderate and high dose of ICS and LABA, LAMA in a very selected asthmatic population, resulting in the market authorisation of these products. However, there is a lack of evidence on the real-world effectiveness of these therapies, especially with regards to improvement in symptom scores and adherence.

Phase—
TypeObservational
Age18 Years
WhereCelje, Slovenia + 17 more
SponsorChiesi Slovenija, d.o.o.
▾Tap for details
Apply

International Severe Asthma Registry_Hong Kong

NCT07524543 · Asthma
Recruiting

To ensure the care of people with severe asthma continues to improve, it is essential we have detailed information on the health and treatment of as many people with the condition as possible. The purpose of the registry is to gather this information and track the progress of patients and how well they are responding to treatment. Medical research using data from the registry will provide a better understanding of asthma and help to develop and improve the care and treatment for patients with asthma. Detailed protocol can be referred to the reference in this trial registration (International severe asthma registry \[ISAR\]: protocol for a global registry).

Phase—
TypeObservational
Age18 Years – 120 Years
WhereHong Kong, Hong Kong
SponsorChinese University of Hong Kong
▾Tap for details
Apply

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

NCT07446985 · Polycystic Ovary Syndrome, Asthma
Recruiting

Women with polysyctic ovarian syndrome (PCOS) usually develop many complications including asthma. Nowdays, diet restriction combimed with phsyical exercises may improve both problems

PhaseNA
TypeInterventional
Age20 Years – 30 Years
WhereGiza, Dokki, Egypt
SponsorCairo University
▾Tap for details
Apply

PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

NCT07143747 · Mild Asthma
Recruiting

The goal of this observational study is to better understand how asthma affects the lungs in young adults (ages 17-35) with mild asthma. The main questions it aims to answer are: * Can advanced imaging detect abnormal airway function in people with mild asthma? * Do changes in ventilation imaging correlate with asthma symptoms or quality of life? Researchers will compare hyperpolarized xenon-129 MRI and Technegas (Tc-99m) imaging to see if these techniques reveal more detailed lung abnormalities than standard lung function tests. Participants will: * Complete a single 2-hour visit * Undergo two types of lung imaging: Hyperpolarized xenon-129 MRI (to visualize how air moves in the lungs), Technegas (Tc-99m) imaging (to assess airflow using nuclear medicine) * Perform spirometry and other breathing tests * Answer questionnaires about asthma symptoms and quality of life This study is designed to improve our understanding of subtle changes in lung function that may not be detected by standard tests in people with mild asthma. The findings may lead to better diagnostic tools and more personalized treatment strategies in the future.

Phase—
TypeObservational
Age17 Years – 35 Years
WhereLondon, Ontario, Canada
SponsorDr. Grace Parraga
▾Tap for details
Apply

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma

NCT06471257 · Asthma
Recruiting

An event-driven, Phase III study to evaluate the efficacy and safety of BDA MDI compared with AS MDI in reducing the risk of a severe asthma exacerbation in symptomatic Chinese adults with asthma.

PhasePhase 3
TypeInterventional
Age18 Years
WhereBaotou, China + 101 more
SponsorAstraZeneca
▾Tap for details
Apply

The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care

NCT07609134 · Asthma, Self-management, Asthma Control
Recruiting

Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives. This research study is taking place to find out if a new education programme, will help adults manage their asthma better and improve the symptoms of asthma, reducing its overall impact on day-to-day life. This study is also looking at how easy it is to introduce and for nurses to deliver this study within a GP/ primary care centre. This study is to find out if this education programme works in a real life setting and if it can lead to better control of asthma for adults.

PhaseNA
TypeInterventional
Age18 Years
WhereDublin, D, Ireland
SponsorRoyal College of Surgeons, Ireland
▾Tap for details
Apply

Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases

NCT07472738 · Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases
Recruiting

This research study focuses on chronic airway diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. These conditions make it difficult for patients to breathe, but breathing difficulty (dyspnea) is often perceived very differently. Some patients may feel severe distress with mild breathing problems, while others might not notice significant breathing issues even when lung function is poor. This difference in perception is termed "dyspnea perception." The main goal of this study is to understand how dyspnea perception varies among patients with chronic airway diseases. The investigators aim to determine if patients can be grouped into different subtypes based on the perception of breathing difficulties. The study will also investigate how these subtypes relate to other treatable characteristics, such as blood cell counts, allergy test results, and findings from lung function tests and brain scans. Approximately 800 patients with COPD or asthma and 150 healthy volunteers will participate. Participants will answer questionnaires, undergo lung function tests, provide blood samples, and a subset will undergo a special brain scan (functional MRI). No new treatments will be assigned; instead, these characteristics will be observed and measured over time. It is hoped that this study will help doctors better understand chronic airway diseases and lead to more personalized management strategies for patients in the future.

Phase—
TypeObservational
Age20 Years – 75 Years
WhereBeijing, Beijing Municipality, China
SponsorBeijing Chao Yang Hospital
▾Tap for details
Apply

Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

NCT00595491 · Asthma
Recruiting

Asthma is a heterogeneous disorder in which multiple potential inflammatory pathways contribute to airway obstruction. The biological basis for airway inflammation is the subject of intensive investigation. This work is designed to identify airway factors that are responsible for recruiting cells and associate their airway presence with atopy and asthma.

PhasePhase 1
TypeInterventional
Age18 Years – 50 Years
WhereBoston, Massachusetts, United States
SponsorBenjamin Medoff
▾Tap for details
Apply

Effect of Acute Hypoxia on RIght VEntRicular Function in Asthma.

NCT07431580 · Hypoxia, Altitude, Hypoxia, Normobaric Hypoxia
Recruiting

More and more people are engaging in sports in the mountains, including individuals with heart or lung diseases. At the same time, such diseases are becoming more common in Switzerland. At high altitude, less oxygen is available, which places stress on the body-particularly on the heart, which has to pump blood through the lungs. How the heart, especially the right ventricle, in people with asthma responds to this stress is still not well understood. Therefore, this study investigates how the heart responds to simulated altitudes of 2,500 m and 4,000 m, both at rest and during light physical activity in patients with asthma. The primary objective is to assess how right ventricular function changes under conditions of reduced oxygen availability. In addition, vital signs, changes in blood gases, oxygen levels in blood and tissue and shortness of breath are assessed. The "altitude" is simulated using a special gas mixture that participants inhale. Participants undergo three altitude conditions (490, 2,500, and 4,000 m above sea level). The order of the altitude conditions is assigned at random. The aim is to better understand how the right ventricle and other parameters respond to low-oxygen conditions and how affected patients can be better supported in the future.

PhaseNA
TypeInterventional
Age18 Years – 80 Years
WhereZurich, Canton of Zurich, Switzerland
SponsorMona Lichtblau
▾Tap for details
Apply

The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)

Recruiting

Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA. The study has two visits approximately one month apart. In the first visit participants will take a spirometry test, particularly forced vital capacity (FVC), to measure volume change in the lungs. Participants will take the investigational device home to use daily, either in the morning or evening. Use will be recorded in a diary. After one month, participants will return for another spirometry test. Each study visit will take about one to two hours to complete.

PhaseNA
TypeInterventional
Age19 Years
WhereOmaha, Nebraska, United States
SponsorUniversity of Nebraska
▾Tap for details
Apply

A Non-interventional, Prospective Study With Benralizumab

NCT06422078 · Asthma, Bronchial
Recruiting

This is a prospective, non-interventional, single-arm, multicenter study to investigate asthma control, and health-related quality of life (HRQL), lung function and asthma medication intake in severe eosinophilic asthma patients treated with benralizumab in a real-life setting in Germany.

Phase—
TypeObservational
Age18 Years – 120 Years
WhereAhrensburg, Germany + 40 more
SponsorAstraZeneca
▾Tap for details
Apply

Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age

NCT05336890 · Premature Birth, Asthma in Children, Sleep-Disordered Breathing
Recruiting

Despite improved survival of extremely premature infants in recent decades, neonatal intensive care unit (NICU) graduates are diagnosed with asthma, sleep disordered breathing (SDB) in childhood, and neurodevelopmental impairments (NDI) at significant rates, disproportionate to their term peers. Early detection and intervention are critical to mitigate the impact of these impairments. Mechanisms leading from premature birth to these undesirable outcomes remain unclear, and accurate prognostic measures are lacking. This study wants to learn if these problems are related to certain patterns of breathing that babies had while they were in the NICU.

Phase—
TypeObservational
Age30 Weeks – 83 Months
WhereChicago, Illinois, United States
SponsorAnn & Robert H Lurie Children's Hospital of Chicago
▾Tap for details
Apply

Methacholine Challenge Test in School Children With/Without Asthma RISKA

NCT07031102 · Asthma Bronchiale, Lung Function Tests, Bronchial Hyperresponsiveness
Recruiting

The study includes a pre-study telephone interview with healthy controls to assess their eligibility for participation. During the study visit, a background information form and an asthma questionnaire are completed. At the study visit, a methacholine challenge test measuring airway hyperresponsiveness and an exhaled nitric oxide measurement are performed. The effect of medication intensification in asthma patients is further assessed through a telephone interview 1-2 months after the medication adjustment.

Phase—
TypeObservational
Age7 Years – 15 Years
WhereHelsinki, Finland
SponsorHelsinki University Central Hospital
▾Tap for details
Apply

Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes

NCT06539312 · Asthma in Children, Directly Observed Therapy
Recruiting

Children with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations. Project ASTHMA (Aligning with Schools To Help Manage Asthma) tests the effectiveness of school-based health centers as a delivery model to improve health outcomes by providing children with guideline-based asthma assessments and preventive medication management, directly observed therapy of their preventive medication to support adherence, and self-management support. If successful, this multicomponent intervention will represent a cost effective and sustainable model to reduce asthma morbidity in historically marginalized communities, and has the potential to impact communities throughout the United States where over 2,500 school-based health centers operate.

PhaseNA
TypeInterventional
Age4 Years – 13 Years
WhereBuffalo, New York, United States
SponsorState University of New York at Buffalo
▾Tap for details
Apply

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

NCT02740868 · Cystic Fibrosis, Asthma
Recruiting

Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung structure and function in participants with cystic fibrosis (CF) and asthma compared to healthy controls.

PhasePhase 2
TypeInterventional
Age8 Years
WhereToronto, Ontario, Canada
SponsorThe Hospital for Sick Children
▾Tap for details
Apply

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

NCT06528418 · Lung Cancer, Lung Infection, COPD
Recruiting

The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are: 1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases. 2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.

Phase—
TypeObservational
Age18 Years – 100 Years
WhereGuangzhou, Guangdong, China
SponsorChromX Health
▾Tap for details
Apply